{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T22:40:13Z","timestamp":1773268813291,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4195,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.fertnstert.2010.03.048","type":"journal-article","created":{"date-parts":[[2010,5,8]],"date-time":"2010-05-08T04:31:31Z","timestamp":1273293091000},"page":"2647-2653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome"],"prefix":"10.1016","volume":"94","author":[{"given":"Susanne","family":"Cupisti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik J.","family":"Giltay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis J.","family":"Gooren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desiree","family":"Kronawitter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia G.","family":"Oppelt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias W.","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Dittrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2010.03.048_bib1","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Position statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib2","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1210\/jc.2007-1834","article-title":"Impact of obesity on the risk for polycystic ovary syndrome","volume":"93","author":"Yildiz","year":"2008","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib3","first-page":"774","article-title":"Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis","volume":"18","author":"Dunaif","year":"1997","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1210\/jc.2003-031122","article-title":"Androgen excess in women: experience with over 1000 consecutive patients","volume":"89","author":"Azziz","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib5","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1093\/humrep\/dep225","article-title":"The relationships between AMH, androgens, insulin resistance and basal ovarian follicular status in nonobese subfertile women with and without polycystic ovary syndrome","volume":"24","author":"Nardo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2265.2009.03598.x","article-title":"Dissociation of endothelial function and arterial stiffness in nonobese women with PCOS","volume":"71","author":"Cussons","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2265.2006.02587.x","article-title":"Obesity and polycystic ovary syndrome","volume":"65","author":"Barber","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib8","first-page":"952","article-title":"The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1530\/eje.1.02195","article-title":"The androgen receptor CAG repeat modifies the impact of testosterone on insulin resistance in women with polycystic ovary syndrome","volume":"155","author":"M\u00f6hlig","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/eje.0.1500363","article-title":"High prevalence of autoimmune thyroiditis in patients with polycystic ovary syndrome","volume":"150","author":"Janssen","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib11","first-page":"57","article-title":"Metformin improves menstrual patterns, endocrine and metabolic profile in obese hyperinsulinemic women with a polycystic ovary syndrome","volume":"27","author":"Krstevska","year":"2006","journal-title":"Prilozi"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib13","doi-asserted-by":"crossref","DOI":"10.1055\/s-0029-1237705","article-title":"The effect of metformin treatment for 2 years without caloric restriction on endocrine and metabolic parameters in women with polycystic ovary syndrome","author":"Oppelt","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib14","first-page":"16","article-title":"[Effect of 6-month treatment with oral antiandrogen alone and in combination with insulin sensitizers on body composition, hormonal and metabolic parameters in women with polycystic ovary syndrome (PCOS) in order to determine therapeutic strategy]","volume":"45","author":"Orbetsova","year":"2006","journal-title":"Akush Ginekol (Sofiia)"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jsbmb.2008.12.022","article-title":"The role of testosterone in the metabolic syndrome: a review","volume":"114","author":"Saad","year":"2009","journal-title":"J Steroid Biochem Molec Biol"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib16","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.fertnstert.2008.06.004","article-title":"Adolescent girls with polycystic ovary syndrome showing different phenotypes have a different metabolic profile associated with increasing androgen levels","volume":"92","author":"Fruzzetti","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib17","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/humrep\/dep121","article-title":"Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype","volume":"24","author":"Rizzo","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.4103\/0019-5359.27971","article-title":"Association of obesity and insulin resistance with dyslipidemia in Indian women with polycystic ovarian syndrome","volume":"60","author":"Kalra","year":"2006","journal-title":"Indian J Med Sci"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib19","doi-asserted-by":"crossref","first-page":"4780","DOI":"10.1210\/jc.2008-1198","article-title":"Prevalence of metabolic syndrome and related characteristics in obese adolescents with and without polycystic ovary syndrome","volume":"93","author":"Rossi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib20","first-page":"19","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","article-title":"Hirsutism and acne in polycystic ovary syndrome","volume":"18","author":"Archer","year":"2004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib22","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ajog.2004.06.064","article-title":"The prevalence of androgen excess among patients with minimal unwanted hair growth","volume":"191","author":"Souter","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib23","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(07)61345-2","article-title":"Polycystic ovary syndrome","volume":"370","author":"Norman","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib24","first-page":"540","article-title":"Evaluation of recommended markers for assessing hyperandrogenemia in women classified as having polycystic ovary syndrome (PCOS) according to the revised 2003 diagnostic criteria","volume":"11","author":"Mueller","year":"2006","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib25","first-page":"403","article-title":"The role of albumin in the calculation of free and bioavailable testosterone in women with hyperandrogenemia","volume":"20","author":"Mueller","year":"2006","journal-title":"In Vivo"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib26","first-page":"35","article-title":"Endocrinological markers for assessment of hyperandrogenemia in hirsute women","volume":"67","author":"Mueller","year":"2007","journal-title":"Horm Res"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib27","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1093\/humrep\/dei070","article-title":"Glucose intolerance, insulin resistance and cardiovascular risk factors in first degree relatives of women with polycystic ovary syndrome","volume":"20","author":"Yilmaz","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib28","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-2006-924062","article-title":"Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone","volume":"114","author":"Mueller","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib29","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1530\/EJE-07-0203","article-title":"Low sex hormone\u2013binding globulin as a predictive marker for insulin resistance in women with hyperandrogenic syndrome","volume":"157","author":"Kajaia","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib30","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1530\/EJE-07-0515","article-title":"Body mass index and ovarian function are associated with endocrine and metabolic abnormalities in women with hyperandrogenic syndrome","volume":"158","author":"Cupisti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib31","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib32","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1055\/s-2006-924233","article-title":"Insulin sensitivity indices: a proposal of cut-off points for simple identification of insulin-resistant subjects","volume":"114","author":"Radikova","year":"2006","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib34","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1055\/s-2007-973059","article-title":"Evaluation of biochemical hyperandrogenemia and body mass index in women presenting with amenorrhea","volume":"115","author":"Cupisti","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib35","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1055\/s-2007-970163","article-title":"Influence of body mass index on calculated androgen parameters in adult women with hirsutism and PCOS","volume":"115","author":"Cupisti","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib36","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1210\/jc.2007-2808","article-title":"Prevalence of polycystic ovary syndrome (PCOS) and hyperandrogenemia in female-to-male transsexuals","volume":"93","author":"Mueller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib37","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1046\/j.1365-2265.2003.01753.x","article-title":"Effects of sex steroids on components of the insulin resistance syndrome in transsexual subjects","volume":"58","author":"Elbers","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib38","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1111\/j.1743-6109.2007.00646.x","article-title":"Review of studies of androgen treatment of female-to-male transsexuals: effects and risks of administration of androgens to females","volume":"5","author":"Gooren","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib39","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1745-7262.2006.00204.x","article-title":"Testosterone decreases adiponectin levels in female to male transsexuals","volume":"8","author":"Berra","year":"2006","journal-title":"Asian J Androl"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2164\/jandrol.108.004952","article-title":"Leptin, ghrelin, and adiponectin evaluation in transsexual subjects during hormonal treatments","volume":"29","author":"Resmini","year":"2008","journal-title":"J Androl"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib41","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1111\/j.1743-6109.2008.00909.x","article-title":"Effects of testosterone undecanoate administered alone or in combination with letrozole or dutasteride in female to male transsexuals","volume":"5","author":"Meriggiola","year":"2008","journal-title":"J Sex Med"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/0026-0495(89)90233-3","article-title":"Mortality and morbidity in transsexual patients with cross-gender hormone treatment","volume":"38","author":"Asscheman","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib43","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1046\/j.1365-2265.1997.2601068.x","article-title":"Mortality and morbidity in transsexual subjects treated with cross-sex hormones","volume":"47","author":"Van Kesteren","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib44","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1590\/S0004-27302006000600008","article-title":"[Insulin resistance and metabolic profile in lean and overweight\/obese polycystic ovary syndrome patients]","volume":"50","author":"Kuba","year":"2006","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib45","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/humrep\/dem005","article-title":"Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review","volume":"22","author":"Costello","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib46","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","volume":"24","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib47","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S1472-6483(10)60165-4","article-title":"Association of thyroid-stimulating hormone with insulin resistance and androgen parameters in women with PCOS","volume":"19","author":"Dittrich","year":"2009","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib48","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1093\/humrep\/dep285","article-title":"Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome","volume":"24","author":"Mueller","year":"2009","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib49","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0b013e32832afd4d","article-title":"Androgens and polycystic ovary syndrome","volume":"16","author":"Nisenblat","year":"2009","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib50","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1210\/jc.2007-0746","article-title":"Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals","volume":"92","author":"Mueller","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib51","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.fertnstert.2007.01.032","article-title":"Risk of metabolic complications in the new PCOS phenotype based on the Rotterdam criteria","volume":"88","author":"Shroff","year":"2007","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib52","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2265.2007.03145.x","article-title":"The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome","volume":"69","author":"Amato","year":"2008","journal-title":"Clin Endocrinol"},{"key":"10.1016\/j.fertnstert.2010.03.048_bib53","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.1.01943","article-title":"High dose estrogen treatment increases bone mineral density in male-to-female transsexuals receiving gonadotropin-releasing hormone agonist in the absence of testosterone","volume":"153","author":"Mueller","year":"2005","journal-title":"Eur J Endocrinol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028210005091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028210005091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:48:36Z","timestamp":1758008916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028210005091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0015028210005091"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2010.03.048","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of testosterone administration to female-to-male transsexuals on insulin resistance and lipid parameters compared with women with polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2010.03.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}